Showing results (271-280 of 554) with videos related to
Sort By:
Pageof 56
Biochemistry|January 31, 2007
Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusionAntony S Dimitrov, Amy Jacobs, Catherine M Finnegan, et al.Virologica Sinica|April 12, 2013
Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1Zhongyu Zhu, Ponraj Prabakaran, Weizao Chen, et al.Experimental and Molecular Pathology|July 20, 2002
Differences between CEM and human peripheral blood T lymphocytes in cAMP-dependent HIV viral fusion and CXCR4 expressionAnthony D Cristillo, Xiaodong Xiao, Regina Campbell-Malone, et al.SAR and QSAR in Environmental Research|October 22, 2011
Simulation of chemical metabolism for fate and hazard assessment. III. New developments of the bioconcentration factor base-line modelS Dimitrov, N Dimitrova, D Georgieva, et al.Translational Oncology|October 3, 2021
Effective killing of cells expressing CD276 (B7-H3) by a bispecific T cell engager based on a new fully human antibodyXianglei Liu, Doncho Zhelev, Cynthia Adams, et al.Experimental and Molecular Pathology|October 6, 2012
Characterization of human IgG repertoires in an acute HIV-1 infectionWeizao Chen, Ponraj Prabakaran, Zhongyu Zhu, et al.Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|August 6, 2010
Properties of the Michael's adducts of the substituted 2-amino-5-oxonitrilesD Tacheva, B B Ivanova, H Mayer-Figge, et al.Emerging Microbes & Infections|June 22, 2017
HIV-1 gp41-targeting fusion inhibitory peptides enhance the gp120-targeting protein-mediated inactivation of HIV-1 virionsQianqian Qi, Qian Wang, Weizao Chen, et al.Frontiers in Oncology|October 25, 2023
Human antibody VH domains targeting uPAR as candidate therapeutics for cancersXiaojie Chu, Wei Li, Margaret G Hines, et al.The Journal of Biological Chemistry|January 18, 2003
Evidence for CD4-enchanced signaling through the chemokine receptor CCR5Robert Staudinger, Sanjay K Phogat, Xiaodong Xiao, et al.Pageof 56